Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
VitaVitro Biotech logo — Advancing IVF solutions for tomorrow's families.

VitaVitro Biotech

Advancing IVF solutions for tomorrow's families.

Founded 2015 China Shenzhen, China 10 employees Series C Total: $15.50M Biotechnology, Health Care

General Information

Company Name VitaVitro Biotech
Founded Year 2015
Location China Shenzhen, China +1
Employees 10
Industries Biotechnology, Health Care
Funding Stage Series C
Social

Get notified when VitaVitro Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VitaVitro Biotech

VitaVitro Biotech is a cutting-edge biotechnology startup based in China, founded in 2015. The company is dedicated to advancing IVF solutions for tomorrow's families with its superior vitrification methods. With its slogan "Advancing IVF solutions for tomorrow's families," VitaVitro is committed to raising standards in IVF technology. Through a robust R&D operation guided by top global expertise, the company aims to modernize IVF processes. In September 2020, VitaVitro Biotech secured a significant $15.50M Series C investment led by Med-Fine Capital and China Capital Investment Group, demonstrating strong investor confidence in its potential to revolutionize the biotechnology and healthcare industries.

Taxonomy: IVF technology, vitrification methods, R&D operation, modernization of IVF processes, family planning, reproductive technology, innovation in fertility treatments, medical advancements, global expertise, fertility solutions, family healthcare, reproductive health, biomedical engineering, medical research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $15.50M 2
Med-Fine Capital China Capital Investment Group
07 Sep 2020

VitaVitro Biotech Alternatives & Competitors

VitaVitro Biotech vs
Conceivable Life Sciences
Conceivable Life Sciences United States

Pioneering the world's first end-to-end automated IVF lab.

Seed
52 employees
Biotechnology, Life Sciences
VitaVitro Biotech vs
IVF Access
IVF Access India

When it comes to IVF, Access is everything.

Series A
66 employees
Health Care
Compare VitaVitro Biotech vs IVF Access
VitaVitro Biotech vs
RMA of New York - Long Island
RMA of New York - Long Island United States

Making families come true.

46 employees
Health Care

FAQ About VitaVitro Biotech

Advancing IVF solutions for tomorrow's families.
VitaVitro Biotech was founded in 2015.
VitaVitro Biotech is headquartered in Shenzhen, China.
VitaVitro Biotech operates in the following industries: Biotechnology, Health Care.
VitaVitro Biotech has approximately 10 employees.
VitaVitro Biotech has completed 1 funding round, raising a total of $15.50M. The latest funding stage is Series C.
Top alternatives and competitors to VitaVitro Biotech include Conceivable Life Sciences, IVF Access, RMA of New York - Long Island, Life Whisperer, Bourn Hall Fertility Clinic UK. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VitaVitro Biotech and Conceivable Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VitaVitro Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy